Hitoshi Nishizawa Selected Research

Percutaneous Coronary Intervention

12/2022	Time-Series Change of Serum Soluble T-Cadherin Concentrations and Its Association with Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction.
8/2017	Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hitoshi Nishizawa Research Topics

Disease

18	Obesity 11/2023 - 04/2002
16	Type 2 Diabetes Mellitus (MODY) 11/2023 - 06/2003
11	Insulin Resistance 01/2019 - 07/2002
9	Body Weight (Weight, Body) 06/2023 - 11/2003
8	Hypertension (High Blood Pressure) 10/2023 - 06/2003
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2023 - 06/2003
7	Non-alcoholic Fatty Liver Disease 07/2023 - 03/2007
7	Acromegaly 12/2015 - 01/2008
6	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 03/2007
6	Neoplasms (Cancer) 01/2022 - 03/2008
6	Hypoadiponectinemia 01/2017 - 09/2002
5	Hypoxia (Hypoxemia) 01/2024 - 03/2008
5	Atherosclerosis 04/2022 - 09/2002
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 09/2002
5	Heart Failure 10/2020 - 09/2011
5	Autoimmune Hypophysitis 11/2019 - 01/2014
5	Inflammation (Inflammations) 11/2016 - 07/2012
4	Fibrosis (Cirrhosis) 01/2022 - 05/2008
4	Coronary Artery Disease (Coronary Atherosclerosis) 06/2006 - 04/2002
3	Dyslipidemias (Dyslipidemia) 10/2023 - 06/2003
3	Hyperglycemia 01/2022 - 09/2003
3	Hypothyroidism 01/2017 - 01/2011
2	Weight Loss (Weight Reduction) 01/2023 - 09/2012
2	ST Elevation Myocardial Infarction 12/2022 - 08/2017
2	Hypertriglyceridemia 09/2022 - 11/2006
2	Neointima 01/2021 - 01/2017
2	Ischemia 01/2021 - 09/2013
2	Cardiomegaly (Heart Hypertrophy) 01/2020 - 02/2014
2	Glucose Intolerance 01/2019 - 01/2011
2	Malnutrition (Nutritional Deficiencies) 01/2018 - 09/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 12/2003
2	Cushing Syndrome 01/2017 - 01/2014
2	Hypertrophy 02/2014 - 03/2011
2	Vascular Diseases (Vascular Disease) 11/2003 - 04/2002
1	Acute Disease 05/2024
1	COVID-19 05/2024
1	Anemia 01/2024
1	Proteinuria 10/2023
1	Vascular Remodeling 07/2023
1	Liver Diseases (Liver Disease) 02/2023
1	Morbid Obesity 01/2023
1	Pancreatitis 09/2022
1	Gout 04/2022
1	Hyperuricemia 04/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2022
1	Overnutrition 04/2022

Drug/Important Bio-Agent (IBA)

32	AdiponectinIBA 05/2024 - 07/2002
14	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 10/2002
13	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 01/2008
12	Insulin (Novolin)FDA Link 11/2023 - 07/2002
11	Growth Hormone (Somatotropin)IBA 01/2017 - 03/2007
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
7	Messenger RNA (mRNA)IBA 02/2014 - 04/2002
6	AdipokinesIBA 05/2024 - 04/2002
5	Triglycerides (Triacylglycerol)IBA 06/2023 - 03/2007
5	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 03/2007
4	Hemoglobins (Hemoglobin)IBA 10/2023 - 01/2016
4	Xanthine DehydrogenaseIBA 07/2023 - 09/2013
4	purineIBA 07/2023 - 09/2013
4	H-cadherin (T-cadherin)IBA 12/2022 - 01/2017
3	Uric Acid (Urate)IBA 02/2023 - 09/2013
3	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2019 - 01/2014
3	ProlactinIBA 01/2017 - 01/2011
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2017 - 01/2011
2	Indicators and Reagents (Reagents)IBA 11/2023 - 01/2014
2	Glutamic Acid (Glutamate)FDA Link 11/2023 - 01/2017
2	HypoxanthineIBA 07/2023 - 01/2018
2	FYX-051IBA 02/2023 - 01/2021
2	MB Form Creatine KinaseIBA 12/2022 - 08/2017
2	Apolipoproteins E (ApoE)IBA 09/2022 - 01/2017
2	LigandsIBA 01/2022 - 03/2007
2	thiazole-4-carboxamide adenine dinucleotide (TCAD)IBA 01/2021 - 01/2017
2	EnzymesIBA 05/2019 - 01/2014
2	Hormones (Hormone)IBA 10/2018 - 10/2002
2	Insulin-Like PeptidesIBA 01/2016 - 06/2012
2	Immunoglobulin G (IgG)IBA 10/2015 - 02/2014
2	Angiotensin IIIBA 02/2014 - 05/2008
2	Liraglutide FDA Link 01/2014 - 09/2012
2	LipidsIBA 01/2014 - 03/2007
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2014 - 09/2012
2	AntioxidantsIBA 03/2011 - 06/2010
2	PPAR alphaIBA 05/2008 - 03/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 07/2002
1	Hypoxia-Inducible Factor 1IBA 01/2024
1	Transcription Factors (Transcription Factor)IBA 01/2024
1	Amino Acids FDA Link 11/2023
1	LDL CholesterolIBA 10/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	InflammasomesIBA 04/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2022
1	ChemokinesIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022

Therapy/Procedure

14	Therapeutics 02/2023 - 06/2006
6	Glycemic Control 01/2023 - 09/2012
3	Bariatric Surgery 01/2023 - 01/2022
2	Percutaneous Coronary Intervention 12/2022 - 08/2017
1	Gastrectomy 01/2023
1	Laughter Therapy 01/2023